Christos Damaskos

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Nikolaos Garmpis · 5 shared papers, 2015–2026 · strength 0.89
   • Paper Liquid biopsy in pancreatic ductal adenocarcinoma from diagnostic accuracy to clinical utility. DOI 10.3389/fonc.2026.1962181↗
   • Paper The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. DOI 10.3390/genes13101868↗
   • Paper Ethical Dilemma: Is it Worthwhile Operating an End-Stage Pancreatic Cancer Patient with Acute Mesenteric Artery Ischemi… DOI 10.15388/amed.2021.28.2.17↗
2. Konstantinos Kossenas · 1 shared paper, 2026 · strength 0.43
   • Paper Liquid biopsy in pancreatic ductal adenocarcinoma from diagnostic accuracy to clinical utility. DOI 10.3389/fonc.2026.1962181↗
3. Panagiotis Sarantis · 2 shared papers, 2022 · strength 0.27
   • Paper The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. DOI 10.3390/genes13101868↗
   • Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736↗
4. Evangelos Koustas · 2 shared papers, 2022 · strength 0.27
   • Paper The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. DOI 10.3390/genes13101868↗
   • Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736↗
5. Efstathios Antoniou · 2 shared papers, 2021–2022 · strength 0.26
   • Paper Ethical Dilemma: Is it Worthwhile Operating an End-Stage Pancreatic Cancer Patient with Acute Mesenteric Artery Ischemi… DOI 10.15388/amed.2021.28.2.17↗
   • Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736↗
6. Gregory P. Kouraklis · 2 shared papers, 2015–2022 · strength 0.17
   • Paper Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What … DOI 10.21873/invivo.12736↗
   • Paper Histone Deacetylase (HDAC) Inhibitors: Current Evidence for Therapeutic Activities in Pancreatic Cancer. PMID 26026072↗
7. Eleni-Myrto Trifylli · 1 shared paper, 2022 · strength 0.15
   • Paper The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. DOI 10.3390/genes13101868↗
8. Michalis V. Karamouzis · 1 shared paper, 2022 · strength 0.15
   • Paper The Emerging Role of MicroRNAs and Autophagy Mechanism in Pancreatic Cancer Progression: Future Therapeutic Approaches. DOI 10.3390/genes13101868↗
9. Stamatios E Theocharis · 1 shared paper, 2015 · strength 0.05
   • Paper Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopat… DOI 10.1186/s12876-015-0379-y↗
10. Ioannis S. Koutsounas · 1 shared paper, 2015 · strength 0.05
    • Paper Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopat… DOI 10.1186/s12876-015-0379-y↗
11. Constantinos Giaginis · 1 shared paper, 2015 · strength 0.05
    • Paper Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopat… DOI 10.1186/s12876-015-0379-y↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.